5 minute read
Jun. 18, 2022

Pevonedistat: a First-In-Class NEDD8-Activating Enzyme (NAE) Inhibitor

pevonedistat

intravenous NEDD8-activating enzyme inhibitor Ph. III candidate for oncology from HTS and optimization Drug Metab. Dispos., July, 2022 Takeda, Lexington, MA

twitterlinkedinprintemail